SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001753926-23-000985
Filing Date
2023-08-02
Accepted
2023-08-02 16:05:29
Documents
13
Period of Report
2023-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K g083677_8k.htm   iXBRL 8-K 25580
2 EXHIBIT 10.1 g083677_ex10-1.htm EX-10.1 154984
  Complete submission text file 0001753926-23-000985.txt   391226

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE lipo-20230802.xsd EX-101.SCH 2956
4 XBRL LABEL FILE lipo-20230802_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE lipo-20230802_pre.xml EX-101.PRE 22357
7 EXTRACTED XBRL INSTANCE DOCUMENT g083677_8k_htm.xml XML 3619
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC (Filer) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 231135486
SIC: 2834 Pharmaceutical Preparations